AGIO
Price
$28.04
Change
-$0.18 (-0.64%)
Updated
May 8 closing price
Capitalization
1.62B
83 days until earnings call
KROS
Price
$14.00
Change
+$0.29 (+2.12%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
556.84M
83 days until earnings call
Ad is loading...

AGIO vs KROS

Header iconAGIO vs KROS Comparison
Open Charts AGIO vs KROSBanner chart's image
Agios Pharmaceuticals
Price$28.04
Change-$0.18 (-0.64%)
Volume$547.58K
Capitalization1.62B
Keros Therapeutics
Price$14.00
Change+$0.29 (+2.12%)
Volume$8.63K
Capitalization556.84M
AGIO vs KROS Comparison Chart
Loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGIO vs. KROS commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGIO is a StrongBuy and KROS is a Buy.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (AGIO: $28.04 vs. KROS: $14.02)
Brand notoriety: AGIO and KROS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGIO: 85% vs. KROS: 73%
Market capitalization -- AGIO: $1.62B vs. KROS: $556.84M
AGIO [@Biotechnology] is valued at $1.62B. KROS’s [@Biotechnology] market capitalization is $556.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGIO’s FA Score shows that 1 FA rating(s) are green whileKROS’s FA Score has 1 green FA rating(s).

  • AGIO’s FA Score: 1 green, 4 red.
  • KROS’s FA Score: 1 green, 4 red.
According to our system of comparison, AGIO is a better buy in the long-term than KROS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGIO’s TA Score shows that 5 TA indicator(s) are bullish while KROS’s TA Score has 3 bullish TA indicator(s).

  • AGIO’s TA Score: 5 bullish, 4 bearish.
  • KROS’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, AGIO is a better buy in the short-term than KROS.

Price Growth

AGIO (@Biotechnology) experienced а -9.37% price change this week, while KROS (@Biotechnology) price change was -3.77% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.66%. For the same industry, the average monthly price growth was +15.23%, and the average quarterly price growth was -12.40%.

Reported Earning Dates

AGIO is expected to report earnings on Jul 31, 2025.

KROS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-3.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGIO($1.62B) has a higher market cap than KROS($557M). KROS YTD gains are higher at: -11.434 vs. AGIO (-14.668). KROS has higher annual earnings (EBITDA): -185.82M vs. AGIO (-420.08M). AGIO has more cash in the bank: 894M vs. KROS (560M). KROS has less debt than AGIO: KROS (18.9M) vs AGIO (57M). AGIO has higher revenues than KROS: AGIO (36.5M) vs KROS (3.55M).
AGIOKROSAGIO / KROS
Capitalization1.62B557M292%
EBITDA-420.08M-185.82M226%
Gain YTD-14.668-11.434128%
P/E Ratio2.45N/A-
Revenue36.5M3.55M1,028%
Total Cash894M560M160%
Total Debt57M18.9M302%
FUNDAMENTALS RATINGS
AGIO: Fundamental Ratings
AGIO
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
18
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
87
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGIOKROS
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
65%
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 8 days ago
75%
Bullish Trend 7 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
AGIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DHSYX21.690.69
+3.29%
Diamond Hill Small Cap Y
CTIGX14.230.35
+2.52%
Calamos Timpani SMID Growth I
MTCHX56.69N/A
N/A
MFS Technology R3
FTGFX27.14N/A
N/A
Templeton Growth R6
PIGWX15.22N/A
N/A
Putnam International Value R6